SOURCE: Hathaway Corporation

January 11, 2007 07:31 ET

Hathaway Corporation (HWYI) Subsidiary, Diabetes Detection, Inc., Plans to Launch Specialized Cellular Phone Service to Healthcare Industry

DDI to Become MVNO for Healthcare Industry

PALO ALTO, CA -- (MARKET WIRE) -- January 11, 2007 -- Hathaway Corporation (PINKSHEETS: HWYI), a leading global provider of communications and telecommunications software and services, today announced that its subsidiary, Diabetes Detection, Inc. ("DDI"), is planning to provide a suite of services and specialized content to the healthcare industry over a cellular network.

The Company is currently exploring several options for providing cellular service as a Mobile Virtual Network Operator ("MVNO"). MVNOs have become popular in recent years with the success of such MVNOs as Amp'd Mobile and Virgin Mobile.

DDI is continuing development of its vibrametric device for diagnosing diabetic neuropathy, and has plans for further testing of the device over the coming weeks. "We believe the combination of DDI's vibrametric device with a healthcare-specific cellular network represents a paradigm shift in the way medical information is managed and disseminated within the healthcare industry," stated Paul D. Lisenby, acting CEO of Hathaway.

About Hathaway Corporation

Hathaway Corporation develops and acquires undervalued companies that bring a shift in how communications is delivered and serviced globally. Starting with OptiCon Systems, which is used by global 500 companies, Hathaway will continue to seek out and capitalize on emerging technologies that will change the way the world communicates. Hathaway brings the communications solutions of the future to today's business marketplace. To request further information about Hathaway, please email us at

Safe Harbor

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.

Contact Information

  • Contact:
    FutureTechIR for Hathaway Corporation
    Investor Relations
    (817) 812-2105
    or 727-417-9338